Lindgren, Peter http://orcid.org/0000-0002-8238-8189
Löfvendahl, Sofia http://orcid.org/0000-0001-7988-757X
Brådvik, Gunnar
Weiland, Ola http://orcid.org/0000-0002-6934-9724
Jönsson, Bengt
Funding for this research was provided by:
Riksbankens Jubileumsfond (P16-0112)
Karolinska Institute
Article History
Received: 30 September 2020
Accepted: 9 November 2021
First Online: 2 December 2021
Declarations
:
: PL, SL and GB are employed by the Swedish Institute for Health Economics, an independent research organization with work funded by different stakeholders in health care, including manufacturers of hepatitis C drugs. OW and BJ reports consultancies and speakers’ bureaus with AbbVie, BMS, Gilead and MSD/Merck.
: The study was approved by the ethical review board in Stockholm (2017/2243-31).